Researchers Identify New Therapeutic Target for Hematologic Malignancies (IMAGE)

Hefei Institutes of Physical Science, Chinese Academy of Sciences

Researchers Identify New Therapeutic Target for Hematologic Malignancies

Caption

Figure 1. Proteasome-mediated degradation of mutant EZH2 proteins. USP47 inhibitor treatment targeted oncogenic EZH2 protein degradation through activation of proteasomal-mediated degradation.

Credit

YANG Jing

Usage Restrictions

no

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.